Advanced search×
×

Vascular Pharmacology

Print ISSN
1537-1891
Electronic ISSN
1879-3649
Impact factor
2.174
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/15371891
Usage rank
4675
Article count
4354
Free count
8
Free percentage
0.00183739
PDFs via platforms
Rcgp, Gale, Sciencedirect, and Ingenta

  1. Biomarkers of inflammation and endothelial function: the holy grail of experimental and clinical medicine?

    Vascular Pharmacology 56(1-2):26 (2012) PMID 22198643

    Drug induced vasculitides in humans are relatively rare diseases, resembling drug-induced vasculitis in rodents and primary idiopathic vasculitis. Because of their exquisite inflammatory nature, vascular lesions in these conditions release a large amount of bioactive molecules and ac...
  2. The effect on ephedrine prodrugs on locomotor activity in rats.

    Vascular Pharmacology 27(1):109 (1996) PMID 8742505

    1. Five oxazolidines were synthesized by reaction of (-) ephedrine with formaldehyde, propionaldehyde, butyraldehyde, isobutyraldehyde, and acetone, respectively. 2. Half-lives of hydrolysis were measured in pH 7.4 aqueous buffer. Half-lives varied from 12 seconds to 11 minutes. 3. The compounds wer...
  3. Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors.

    Vascular Pharmacology 62(1):15 (2014) PMID 24792896

    We performed studies in isolated and perfused mesenteric arterial rings. A 20-h exposure of the rings to lipopolysaccharide (LPS, 1 μg/ml) led to hyporeactivity to phenylephrine (PE). However, the responses of the LPS-treated rings to high concentrations of KCl (60 mM) and ATP remained comparable to...
  4. Cyclopiazonic acid alters serotonin-induced responses in rat thoracic aorta.

    Vascular Pharmacology 61(2-3):43 (2014) PMID 24704610

    We previously showed that endothelin A (ETA) receptor antagonist BQ-123 partially inhibited cyclopiazonic acid (CPA)-enhanced endothelin-1 (ET-1)-induced contractions suggesting enhancement of ETA receptor internalization in caveolar structures by sarco/endoplasmic reticulum Ca+2 ATPase (SERCA) bloc...
  5. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway.

    Vascular Pharmacology 60(3):110 (2014) PMID 24534483

    We assessed the effect of wogonin on angiogenesis induced by low level of H2O2 (10 μM) in human umbilical vein endothelial cells (HUVECs). Wogonin suppressed H2O2-induced migration and tube formation of HUVECs as well as microvessel sprouting from rat aortic rings in vitro. Meanwhile, wogonin suppre...
  6. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update.

    Vascular Pharmacology 58(4):259 (2013) PMID 23313806

    Diabetes mellitus is known to trigger retinopathy, neuropathy and nephropathy. Diabetic nephropathy, a long-term major microvascular complication of uncontrolled hyperglycemia, affects a large population worldwide. Recent findings suggest that numerous pathways are activated during the course of dia...
  7. Suppression of endothelial cell adhesion by XJP-1, a new phenolic compound derived from banana peel.

    Vascular Pharmacology 57(2-4):105 (2012) PMID 22609942

    We report that (±) 7, 8-dihydroxy-3-methyl-isochromanone-4 (XJP-1), an inhibitor of ox-LDL-induced adhesion of monocytes to endothelial cells blocks cellular functions which are associated with adhesion. We show that XJP-1 down-regulates ox-LDL-induced over-expression of adhesion molecules (ICAM-1 a...
  8. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R...

    Vascular Pharmacology 57(1):56 (2012) PMID 22459073

    We here examined the effect of FTY720 and a selective S1P receptor type 1 agonist CYM5442 on atherosclerosis in moderately hypercholesterolemic LDL-R−/− mice....
  9. All cut up! The consequences of calpain activation on platelet function.

    Vascular Pharmacology 56(5-6):210 (2012) PMID 22386643

    The Ca(2+)-activated proteases or calpains, play a crucial role in a specific spectrum of physiological processes such as cytoskeletal remodeling, cellular signaling, cell migration, apoptosis, cell survival and platelet activation, by the proteolytic cleavage of target proteins. Rat...
  10. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.

    Vascular Pharmacology 56(1-2):91 (2012) PMID 22166585

    The increased proliferation of vascular smooth muscle cells (VSMCs) in the arterial wall is a critical pathogenic factor for vascular diseases such as atherosclerosis and restenosis after angioplasty. Clitocybin B was reported to have either a potent free radical scavenging effect or...